Egypt’s Eva Pharma gears up to roll out veterinary vaccines from its new complex

Made-in-Egypt veterinary vaccines: Eva Pharma’s veterinary pharma arm, Eva Pharma Animal Health, completed the first phase of its veterinary vaccine complex in 6th of October, Managing Director Ahmed Waked told Asharq Business. The first of its products — poultry vaccination against the bird flu — will hit the market later this month.

The price tag? The company has already invested EGP 980 mn on the first phase of the EGP 1.8 bn complex — excluding tech and scientific research investments.

What’s next? Eva Pharma Animal Health plans to inaugurate three more phases to the complex over the coming six years, which will produce vaccines for cattle and poultry, Waked said. The company also wants to double the complex’s production capacity to 2.4 bn doses per year by 2028, half of which will be earmarked for exports.

Tapping into the Saudi market: The veterinary drugmaker wants to export its vaccines to the Saudi market by the beginning of 2025, Waked said, adding that the firm is currently working to meet the technical requirements that will allow it to enter the Kingdom.

ICYMI: Eva Pharma inked an agreement with the Saudi Authority for Industrial Cities and Technology Zones in September to build a USD 133 mn industrial complex for pharma research and manufacturing in the Saudi Sudair Industrial City. The complex will kick off the first phase of operations in April 2025 and will reach full operational capacity the following year.